Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangwei Huangyangxing D injection for stable angina pectoris
CTR20132431Phase 2Completed
- Sponsor
- Hefei Innovation Pharmaceutical Technology
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclovirobuxine D in coronary arteriosclerosis, angina pectoris, sponsored by Hefei Innovation Pharmaceutical Technology. Started Feb 2014; status: completed.
02
Drugs
cyclovirobuxine D
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20132431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132431.